{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T14:42:50Z","timestamp":1698504170785},"reference-count":44,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,8,23]],"date-time":"2005-08-23T00:00:00Z","timestamp":1124755200000},"content-version":"vor","delay-in-days":2701,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Japanese Journal of Cancer Research"],"published-print":{"date-parts":[[1998,4]]},"abstract":"<jats:p>The anti\u2010tumor activity of human peripheral blood mononuclear cells (PBMC) against various tumor cell line cells (K562, Daudi, KMG\u20102, and KATOIII) was enhanced by coculture with irradiated BALL\u20101, but not with other irradiated B cell line cells (NALM\u20101, Namalwa, and Daudi). PBMC cocultured with BALL\u20101, however, failed to exhibit evident cytotoxicity against autologous concanavalin A\u2010induced lymphoblasts. The enhancement of the anti\u2010tumor activity seemed not to be correlated with EBNA and HLA\u2010DR expression on B cell line cells. Monoclonal antibodies (mAbs) against interleukin (IL)\u20102, interferon\u2010\u03b3, IL\u201012, IL\u201015, tumor necrosis factor\u2010\u03b1 and lymphotoxin showed little or no suppression of the anti\u2010tumor activity of PBMC treated with irradiated BALL\u20101. Furthermore, the culture supernatants of BALL\u20101 failed to enhance the anti\u2010tumor activity of PBMC, suggesting no involvement of soluble factors in the induction of the anti\u2010tumor activity. The anti\u2010tumor activity of PBMC treated with BALL\u20101 was synergistically enhanced by an additional IL\u20102 stimulation. Periodate\u2010lysine\u2010paraformaldehyde\u2010fixed, but not ethanol\u2010 or acetone\u2010fixed, BALL\u20101 could significantly enhance the anti\u2010tumor activity. Furthermore, BALL\u20101\u2010derived membrane fraction, but not that of Daudi, enhances the anti\u2010tumor activity. It was thus suggested that some membrane glycoproteins on the cell surface of BALL\u20101 play a crucial role in the induction of the anti\u2010tumor activity. By analysis using mAbs against human leukocytes, we found that depletion of CD11b, CD16, and CD56\u2010positive cells resulted in decreased anti\u2010tumor activity, suggesting that the main effector cells in the BALL\u20101\u2010induced anti\u2010tumor activity were natural killer (NK) cells. The present results thus raise the possibility that BALL\u20101, probably via membrane glycoproteins, modulates NK cell\u2010mediated anti\u2010tumor activity.<\/jats:p>","DOI":"10.1111\/j.1349-7006.1998.tb00581.x","type":"journal-article","created":{"date-parts":[[2005,8,23]],"date-time":"2005-08-23T14:40:09Z","timestamp":1124808009000},"page":"427-435","source":"Crossref","is-referenced-by-count":0,"title":["Enhancement of Anti\u2010tumor Activity of Natural Killer Cells by BALL\u20101, a B Cell Lymphoma Line"],"prefix":"10.1111","volume":"89","author":[{"given":"Mitsuomi","family":"Hirashima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masako","family":"Seki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seishi","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yosuke","family":"Mihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,23]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/262691a0"},{"key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4049\/jimmunol.127.1.266","article-title":"Lysis of human solid tumors by autologous cells sensitized in vitro to alloantigens","volume":"127","author":"Strausser J. L.","year":"1981","journal-title":"J. Immunol."},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1978.217"},{"key":"e_1_2_1_5_2","first-page":"1407","article-title":"Human tumor\u2010lymphocyte interaction in vitro. VI. Specificity of primary and secondary autologous lymphocyte\u2010mediated cytotoxicity","volume":"62","author":"Vanky F.","year":"1979","journal-title":"J. Natl. Cancer Inst."},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910270304"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.155.6.1823"},{"key":"e_1_2_1_8_2","first-page":"4420","article-title":"Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T\u2010cell growth factor","volume":"41","author":"Lotze M. T.","year":"1981","journal-title":"Cancer Res."},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.148.6.1523"},{"key":"e_1_2_1_10_2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1182\/blood.V57.3.379.379","article-title":"Human T lymphocyte growth factor: regulation of growth and function of T lymphocytes","volume":"57","author":"Ruscetti F. W.","year":"1981","journal-title":"Blood"},{"key":"e_1_2_1_11_2","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.4049\/jimmunol.126.4.1318","article-title":"Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially sensitized in vivo and in vitro and nonspecifically expanded by culture with interleukin 2","volume":"126","author":"Cheever M. A.","year":"1981","journal-title":"J. Immunol."},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910290107"},{"key":"e_1_2_1_13_2","first-page":"385","article-title":"Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in IL\u20102","volume":"156","author":"Eberlein T. J.","year":"1982","journal-title":"J. Exp. Med."},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(83)90045-2"},{"key":"e_1_2_1_15_2","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4049\/jimmunol.131.1.186","article-title":"Human cytotoxic T cell clones directed at autologous virus\u2010transformed targets: further evidence for linkage of genetic restriction of T4 and T8 surface glycoproteins","volume":"131","author":"Meuer S. C.","year":"1983","journal-title":"J. Immunol."},{"key":"e_1_2_1_16_2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.4049\/jimmunol.135.1.703","article-title":"Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus\u2010induced syngeneic T cell leukemia: viral gp70 antigen\u2010specific MT4+ clones and Lyt\u20102+ cytolytic clones which recognize a tumor\u2010specific cell surface antigen","volume":"135","author":"Matis L. A.","year":"1985","journal-title":"J. Immunol."},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(93)90100-G"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2478(94)90146-5"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000237706"},{"key":"e_1_2_1_20_2","first-page":"25","article-title":"Establishment and characterization of 5 cell lines derived from human brain tumors","volume":"39","author":"Mihara Y.","year":"1986","journal-title":"Kumamoto Med. J."},{"key":"e_1_2_1_21_2","first-page":"61","article-title":"Establishment of cultured cell lines derived from a human gastric carcinoma","volume":"48","author":"Sekiguchi M.","year":"1978","journal-title":"Jpn. J. Exp. Med."},{"key":"e_1_2_1_22_2","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/S0021-9258(18)89560-6","article-title":"Tumor necrosis factor: production, purification, and characterization","volume":"260","author":"Aggarwal B. B.","year":"1985","journal-title":"J. Biol. Chem."},{"key":"e_1_2_1_23_2","first-page":"257","article-title":"Production and characterization of interferon from human leukemic lymphoblastoid cells grown in hamsters","volume":"2","author":"Imanishi J.","year":"1980","journal-title":"J. Appl. Biochem."},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/S0021-9258(18)89559-X","article-title":"Primary structure of human lympho\u2010toxin derived from 1788 lymphoblastoid cell line","volume":"260","author":"Aggarwal B. B.","year":"1985","journal-title":"J. Biol. Chem."},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.17.5397"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/310145a0"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530040404"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.4049\/jimmunol.136.5.1688","article-title":"In vitro production of interleukin 1 by normal and malignant human B lymphocytes","volume":"136","author":"Pistoia V.","year":"1986","journal-title":"J. Immunol."},{"key":"e_1_2_1_29_2","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.4049\/jimmunol.133.6.3133","article-title":"A B cell growth factor\u2010like activity is secreted by cloned, neoplastic B cells","volume":"133","author":"Brooks K. H.","year":"1984","journal-title":"J. Immunol."},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1979.tb01348.x"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1128\/iai.41.3.992-997.1983","article-title":"Inter\u2010leukin\u20102 enhances natural killer cell activity through induction of gamma interferon","volume":"41","author":"Weigent D. A.","year":"1983","journal-title":"Infect. Immunol."},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/291335a0"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.170.3.827"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.180.4.1395"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.158.4.1356"},{"key":"e_1_2_1_36_2","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.4049\/jimmunol.131.4.1827","article-title":"Activation of nonspecific killer cells by interleukin 2\u2010containing supernatants","volume":"131","author":"Teh H. S.","year":"1983","journal-title":"J. Immunol."},{"key":"e_1_2_1_37_2","first-page":"1946","article-title":"Lymphokine\u2010activated killer cells: lysis of fresh syngeneic natural killer\u2010resistant murine tumor cells by lymphocytes cultured in interleukin 2","volume":"44","author":"Rosenstein M.","year":"1984","journal-title":"Cancer Res."},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1983.tb01072.x"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(84)90078-9"},{"key":"e_1_2_1_40_2","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.4049\/jimmunol.137.9.2814","article-title":"Interleukin 2\u2010activated human killer cells are derived from phenotypically heterogeneous precursors","volume":"137","author":"Damle N. K.","year":"1986","journal-title":"J. Immunol."},{"key":"e_1_2_1_41_2","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.4049\/jimmunol.136.4.1454","article-title":"Natural cytotoxicity against mouse hepatitis virus\u2010infected cells. II. A cytotoxic effector cell with a B lymphocyte phenotype","volume":"136","author":"Welsh R. M.","year":"1986","journal-title":"J. Immunol."},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1993.tb03378.x"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/311750a0"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1159\/000233561"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1177\/22.12.1077"}],"container-title":["Japanese Journal of Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.1998.tb00581.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.1998.tb00581.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T01:55:41Z","timestamp":1698458141000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.1998.tb00581.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1998,4]]}},"alternative-id":["10.1111\/j.1349-7006.1998.tb00581.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.1998.tb00581.x","archive":["Portico"],"relation":{},"ISSN":["0910-5050"],"issn-type":[{"value":"0910-5050","type":"print"}],"subject":[],"published":{"date-parts":[[1998,4]]}}}